• 142,173+ Medical Conferences
  • 273 Specialties
  • 10,716 Organizers
  • 153,596 Speakers
  • 156 Countries
  • 4,630 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Ajay K. Gopal
Ajay K. Gopal

Ajay K. Gopal

Professor | Seattle, Washington    United States Of America
Oncology, Precision Oncology Medicine
Hodgkins Lymphoma, Oncology,...More
Spoken at 3 events

Biography :

Reflecting on his role as a lymphoma physician researcher, Ajay K. Gopal, MD, said the process of "going from seeing a patient in the clinic to understanding the biology of the disease and ultimately addressing the clinical need" keeps him engaged and excited about his work. The two-time Lymphoma Research Foundation (LRF) Mantle Cell Lymphoma Initiative Award recipient has had a busy 2011, leading and collaborating on several groundbreaking publications related to his work in targeted radiation immunotherapy.

In July, Dr. Gopal was the first author on a study published in the prestigious journal Blood examining a new treatment regimen for patients with persistent high-risk B-cell lymphoma with the drugs 90Y-ibritumomab tiuxetan and fludarabine alongside non-myeloablative allogeneic transplantation (NMAT). After treating 40 patients in the trial and following their disease progression for five years, the team determined that not only is adding 90Y-ibritumomab tiuxetan to NMAT safe, but it also showed beneficial effects on disease progression and control.

This section has yet to be updated by the speaker.
For speaker's contact information - Contact us


Oncology, Precision Oncology medicine

Interested Topics

Hodgkins lymphoma, Oncology, Chronic lymphocytic leukemia, Diffuse large B-cell lymphoma, Follicular lymphoma, Low-grade lymphoma, MALT, Mantle cell lymphoma, Marginal zone lymphoma

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Send Message